DAFNA Capital Management LLC - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2013$2,740,000
-18.1%
148,915
-22.1%
2.99%
-38.8%
Q2 2013$3,344,000191,2154.89%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders